CHEK2 and acute myeloid leukemia: We found no driver mutations in TET2, DNMT3A, PPM1D, IDH1, IDH2, TP53, CHEK2, ASXL1, MBD4 or other genes associated with myelodysplasia or AML, and the patient has reported no haematological problems in over two decades of follow-up.